Price T Rowe Associates Inc Ligand Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

  • $935 Billion
  • Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 18,915 shares of LGND stock, worth $3.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,915
Previous 17,968 5.27%
Holding current value
$3.8 Million
Previous $2.04 Million 63.99%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$112.56 - $177.14 $106,594 - $167,751
947 Added 5.27%
18,915 $3.35 Million
Q2 2025

Aug 14, 2025
BUY
$96.67 - $118.22 $160,472 - $196,245
1,660 Added 10.18%
17,968 $2.04 Million
Q1 2025

May 14, 2025
BUY
$105.14 - $122.23 $83,060 - $96,561
790 Added 5.09%
16,308 $1.72 Million
Q4 2024

Feb 14, 2025
BUY
$99.95 - $129.9 $178,010 - $231,351
1,781 Added 12.96%
15,518 $1.66 Million
Q3 2024

Nov 14, 2024
BUY
$82.7 - $110.11 $12,074 - $16,076
146 Added 1.07%
13,737 $1.38 Million
Q2 2024

Aug 14, 2024
BUY
$68.53 - $87.91 $41,049 - $52,658
599 Added 4.61%
13,591 $1.15 Million
Q1 2024

May 15, 2024
BUY
$68.64 - $89.2 $41,870 - $54,412
610 Added 4.93%
12,992 $951,000
Q4 2023

Feb 14, 2024
BUY
$49.57 - $72.63 $42,630 - $62,461
860 Added 7.46%
12,382 $885,000
Q3 2023

Nov 14, 2023
BUY
$58.86 - $72.67 $64,981 - $80,227
1,104 Added 10.6%
11,522 $692,000
Q2 2023

Aug 14, 2023
BUY
$69.53 - $79.33 $58,057 - $66,240
835 Added 8.71%
10,418 $752,000
Q1 2023

May 15, 2023
BUY
$65.67 - $77.08 $71,383 - $83,785
1,087 Added 12.79%
9,583 $705,000
Q4 2022

Feb 14, 2023
BUY
$61.72 - $96.74 $13,516 - $21,186
219 Added 2.65%
8,496 $568,000
Q3 2022

Nov 14, 2022
BUY
$0.01 - $107.56 $12 - $138,107
1,284 Added 18.36%
8,277 $713,000
Q2 2022

Aug 15, 2022
SELL
$74.52 - $117.06 $84,580 - $132,863
-1,135 Reduced 13.96%
6,993 $624,000
Q1 2022

May 16, 2022
BUY
$94.99 - $151.56 $59,463 - $94,876
626 Added 8.34%
8,128 $914,000
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $158,846 - $206,317
-1,244 Reduced 14.22%
7,502 $1.16 Million
Q3 2021

Nov 15, 2021
SELL
$102.33 - $144.73 $63,444 - $89,732
-620 Reduced 6.62%
8,746 $1.22 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $99,353 - $136,807
-879 Reduced 8.58%
9,366 $1.23 Million
Q1 2021

May 17, 2021
SELL
$99.52 - $215.83 $5.33 Million - $11.6 Million
-53,573 Reduced 83.95%
10,245 $1.56 Million
Q4 2020

Feb 16, 2021
BUY
$80.55 - $106.05 $5.14 Million - $6.77 Million
63,818 New
63,818 $6.35 Million

Others Institutions Holding LGND

# of Institutions
343
Shares Held
20.5M
Call Options Held
19K
Put Options Held
11.5K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.39B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email